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Geranylgeranylacetone ameliorates ischemic acute renal failure
via induction of Hsp70
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Geranylgeranylacetone ameliorates ischemic acute renal failure
via induction of Hsp70.
Background. Heat shock proteins (HSPs) are well known
as cytoprotective proteins. Geranylgeranylacetone (GGA), an
antiulcer agent, has recently been shown to induce Hsp70. This
study was performed to investigate the renoprotective proper-
ties of GGA.
Methods. The effect of GGA on the induction of the major
HSPs (Hsp90, Hsp70, Hsc70, Hsp60, and Hsp32) was studied in
the rat kidney or rat primary cultures of tubular epithelial cells
(R-TECs) by Western blot. Localization of Hsp70 was deter-
mined by immunohistochemistry. The renoprotective effects of
GGA were studied using a rat model of ischemia/reperfusion
(I/R) injury. GGA (400 mg/kg), GGA with quercetin pretreat-
ment (100 mg/kg), or a vehicle was given to rats 24 hours and
again 1 hour prior to the induction of I/R injury. Rats were sac-
rificed at 24 hours after reperfusion. Histologic analyses and
terminal deoxynucleotidyl transferase (TdT)-mediated de-
oxyuridine triphosphate (dUTP) nick-end labeling (TUNEL)
assay were performed. Blood urea nitrogen (BUN) and serum
creatinine was also measured. The cytoprotective properties
of GGA were also studied in vitro by treating R-TECs with
GGA (10 lmol/L) or a vehicle, followed by incubation in
culture medium with oxidative stress condition (0.5 mmol/L
hydrogen peroxide) or ischemic condition (2 nmol/L NaCN
and 20 mmol/L 2-deoxyglucose in the absence of medium
glucose).
Results. Oral administration of GGA induced Hsp70 expres-
sion in the kidney (which peaked at 24 hours) but did not in-
duce Hsp90, Hsc70, Hsp60, or Hsp32. The induction of Hsp70
was blocked by quercetin. Immunohistochemistry showed that
Hsp70 was localized mainly in the tubular epithelial cells. Pre-
conditioning rats with GGA significantly decreased BUN and
serum creatinine levels after I/R injury. Histologic examination
revealed that GGA significantly attenuated tubular damage and
macrophage infiltration. The number of TUNEL-positive cells
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also decreased significantly in the GGA group. Quercetin, an
inhibitor of Hsp70 induction, eliminated these renoprotective
effects of GGA. In in vitro study, GGA-induced Hsp70 in R-
TECs, which peaked at 2 to 4 hours. Both oxidative stress and is-
chemic stimuli induced apoptosis in R-TECs. GGA significantly
suppressed the number of apoptotic cells in both conditions.
Conclusion. The results support the hypothesis that GGA
induces Hsp70, protects tubular epithelial cells from apoptosis,
and thus ameliorates tubular damage by I/R injury. The present
study suggests that GGA would be a useful tool in treating acute
renal failure or preventing transplanted kidney damage in the
clinical setting.
Acute renal failure (ARF) is a major clinical problem
and the morbidity and mortality of affected patients re-
main unacceptably high [1–3]. Current therapies are lim-
ited to supportive measures and preventive strategies,
none of which have been definitively shown to alter mor-
tality [1, 4]. ARF is often associated with multiple or-
gan failure. Despite the complexity of multiorgan illness,
the presence of ARF independently carries a marked in-
crease in mortality. Ischemia/reperfusion (I/R)-induced
renal injury is the most common cause of ARF [5]. It oc-
curs when renal perfusion is reduced during shock. It is
also a significant complication of vascular surgery of the
aorta or kidney [6]. In addition, I/R injury is unavoidable
in renal transplantation, and occurs during organ retrieval
and storage. I/R injury is closely associated with increased
acute rejection episodes and late allograft failure [7, 8].
These problems are almost always observed in cadav-
eric renal allografts that have been subjected to warm or
cold ischemia, then reperfusion. The unsatisfactory re-
sults from such transplants hamper efforts to enlarge the
donor pool through the use of marginal donor organs [9].
Therefore, efforts to reduce damage to kidneys exposed
to I/R-induced injury are essential.
Although the etiology of I/R injury is complex, insult
by oxygen free radicals [10] and attack following inflam-
matory response have been considered important factors
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[7]. Numerous studies have shown that the antioxidative
status of the organ is of great importance for primary
endogenous defense against free radical–induced injury.
Various exogenous antioxidants, including a-tocopherol,
lazaroid, probucol, and scavenger superoxide dismutase
(SOD) have been reported to prevent I/R injury of the
kidney [1]. Other studies have identified various inflam-
matory mediators as likely being involved: tumor necro-
sis factor-a (TNF-a), intercellular adhesion molecule-1
(ICAM-1), P-selectin, platelet-activating factor, Groa(
macrophage inflammatory protein-2 (MIP-2), mono-
cyte chemoattractant protein-1 (MCP-1), midkine, etc.
Therapeutic intervention targeting these molecules has
successfully been shown to attenuate renal I/R injury in
experimental animals [1, 3].
In spite of the all the studies mentioned above, noth-
ing has proven effective in humans [1, 4]. Attention has
recently been focused on the induction of ischemic toler-
ance. This is a rational approach because it is based on an
innate defense mechanism. The concept of ischemic toler-
ance is founded on the premise that sub-lethal heat shock
or low-grade ischemic injuries produce tolerance in cells
and tissues to subsequent exposure to heat or ischemic in-
jury [11]. The mechanistic basis of this tolerance has not
been fully delineated, but heat shock proteins (HSPs) are
thought to play important roles in this process. Pharma-
cologic agents that induce the expression of HSPs have
vigorously been sought. However, several agents which
could induce the expression of HSPs are also known to
be toxic or to have harmful side effects [12–14]. There-
fore, it would be of great therapeutic benefit to discover
nontoxic compounds that can effectively induce HSPs in
the kidney.
Geranylgeranylacetone (GGA), an acyclic polyiso-
prenoid, is an antiulcer drug developed in Japan which
has been used clinically to treat gastritis or gastric ul-
cers since 1984 without serious adverse reactions. GGA
is known to induce overexpression of the Hsp70 family in
the gastric mucosa and small intestine of rats when given
orally [15, 16]. Recently, the organ protective effect of
GGA has been shown in the heart [17] and liver [18, 19].
To date, whether GGA induces Hsp70 expression in the
kidney has not been studied. Nor has any renoprotec-
tive effect on I/R injury been demonstrated. The present
study was therefore performed to evaluate whether
GGA can indeed induce ischemic tolerance in the
kidney.
METHODS
Animals
Male Sprague-Dawley rats weighing 250 to 300 g were
purchased from Chubu Kagaku Shizai Co. Ltd. (Nagoya,
Japan) and were allowed free access to food and water.
The experiments were performed according to the An-
imal Experimentation Guidelines of Nagoya University
Graduate School of Medicine (Nagoya, Japan).
Analysis of Hsp70 expression in vivo
In order to determine the optimal dosage for the induc-
tion of Hsp70 in the kidney, various dosages of GGA (0,
200, 400, or 800 mg per kg body weight), were orally given
to rats as an emulsion with 5% gum arabic and 0.008%
tocopherol. GGA was provided by Eisai Co., Ltd (Tokyo,
Japan). Rats were sacrificed by deep anesthesia with pen-
tobarbital (50 mg/kg intraperitoneally) at 24 hours af-
ter administration of GGA or vehicle. The kidney was
rapidly removed and the whole kidney homogenate was
used for the Western blot analysis.
To examine the time-course of the Hsp70 expres-
sion, kidneys were harvested at 12, 24, and 48 hours
after the administration of a single oral dose of GGA
(400 mg/kg). The expression of Hsp70 was also studied
after delivering two oral doses of GGA (400 mg/kg); one
at 0 hour, another at 24 hours, prior to harvesting the
kidneys at 48 hours. One part of the kidney was used for
Western blot analysis, and another part was frozen in 22-
oxacalcitriol (OCT) compound (Miles, Elkhart, IN, USA)
for immunostaining. Six rats were used in each group.
To study the effects of quercetin on the Hsp70 induc-
tion, rats were given 100 mg/kg of quercetin 2 hours prior
to GGA administration (400 mg/kg), and kidneys were
harvested at 24 hours.
Experimental protocol of I/R study
Rats in the GGA group (N = 6) were orally given GGA
(400 mg/kg) at 24 hours and again at 1 hour before start-
ing the surgery. Rats in the quercetin group (N = 6) were
given GGA, in the same way as in the GGA group, follow-
ing the intraperitoneal injection of quercetin (100 mg/kg)
2 hours before each GGA administration. Control rats
(N = 6) were given the same volume of vehicle. Rats
were anesthetized by the intraperitoneal injection of pen-
tobarbital sodium (50 mg/kg body weight), and the body
temperature was maintained on a heating pad (37◦C).
Both kidneys were exposed by a midline incision and is-
chemia was induced by clamping bilateral renal arteries
and veins for 30 minutes with a 25 mm microaneurysm
clamp. After removal of clamps, the muscle and skin were
sutured separately. Rats were sacrificed at 24 hours after
I/R injury, and blood and kidney samples were collected
for the study.
Additional experiment was performed to study the
time course of I/R injury. Rats were treated with GGA
(400 mg/kg) (N = 6) or a vehicle (N = 6) at 24 hours and 1
hour before the surgery. Blood samples were taken from
the postorbital vein just before (0 hour), and 1, 2, 3 and
7 days after I/R injury.
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Histology and immunohistochemistry
One part of the kidney was fixed with 4% para-
formaldehyde, embedded in paraffin, and cut into 4
lm sections. These were stained with periodic acid-
Schiff (PAS) reagent. Immunostaining for Hsp70 was per-
formed as previously described [20] with minor modi-
fication. Briefly, sections were deparaffinized, placed in
buffered citrate (10 mmol/L, pH 6.0), and heated in a
microwave oven (250 W) for 15 minutes. The sections
were then incubated with monoclonal antibodies against
rat Hsp70 (SPA-810) (Stress Gen Biotechnologies Corp.,
Victoria, BC, Canada) or normal mouse IgG, followed
by a conjugate of polyclonal goat antimouse IgG anti-
bodies (Envision+) (Dako, Glostrup, Denmark) as the
second reagent. Another part of the kidney was frozen
in OCT compound (Miles). Sections (2 lm thick) were
fixed in acetone. Monocytes/macrophages were stained
as previously described [21]. The primary antibodies em-
ployed was monoclonal antibodies against ED-1 (antirat
macrophages/monocytes) (Serotec, Raleigh, NC, USA)
and the secondary antibodies were fluorescein conjugates
of goat antimouse IgG antibody (Zymed Laboratories,
San Francisco, CA, USA).
Morphometric analysis of histology and
immunohistochemistry
To assess tubulointerstitial injury, kidney sections were
analyzed using a semiquantitative grading as described
previously [21] with minor modification. Briefly, the ex-
tent of tubular cast formation and tubular damage (di-
latation and degeneration) in 16 nonoverlapping fields
(×200) of the outer medulla was scored according to the
following criteria (0, normal; 1, less than 30%; 2, 30% to
70%; and 3, more than 70% of the pertinent area). Inter-
stitial macrophage infiltration was assessed by counting
ED-1 positive cells in 16 nonoverlapping fields (×400)
of the outer medulla, and expressed per field. The mor-
phologic analysis was carried out by two observers in
a blind fashion, using a Zeiss microscope (Oberkochen,
Germany).
Fig. 1. Induction of heat shock proteins (HSPs) at 24 hours after
oral geranylgeranylacetone (GGA). (A) Dose-dependent expression of
Hsp70 at 24 hours after oral GGA was analyzed by Western blot. Hsp70
expression increased significantly in rats given 400 mg/kg of GGA, but
the dose of 800 mg/kg did not induce further increase. ∗P < 0.05 ver-
sus vehicle treated rats. (B) Immunohistochemistry revealed that a low
level of Hsp70 expression was observed in the normal rat kidney. (C)
GGA administration enhanced the expression of Hsp70 especially in
the inner stripe of outer medulla. (D) The expression of other HSPs
was also studied by Western blot. Hsp90, Hsc70, Hsp60 or Hsp32 was
not induced in the kidney at 24 hours after administration GGA (400
mg/kg).
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Fig. 2. The time-course of heat shock protein (Hsp70) expression. The
level of Hsp70 expression was studied at 12, 24, and 48 hours after a
single oral dose of geranylgeranylacetone (GGA) (400 mg/kg). Hsp70
had started to increase by 12 hours, peaked at 24 hours, and had declined
by 48 hours. No time-dependent change was observed in the expression
of Hsp70 in the vehicle group. Hsp70 expression was also examined at
48 hours, after two oral doses (at 0 hour and 24 hours) of GGA (400
mg/kg). The peak level of Hsp70 expression was comparable to that
induced by a single oral dose at 24 hours. Symbols are: vehicle ();
GGA (). ∗P < 0.05 versus vehicle-treated rats.
Measurement of blood urea nitrogen (BUN) and
serum creatinine
Upon completion of the in vivo experiment, blood was
taken from the aorta, and serum was collected. BUN
and serum creatinine levels were measured using Daiya
Auto UN or Daiya Auto Crea Kit (Daiya Shiyaku, Tokyo,
Japan).
Isolation and culture of rat proximal tubular
cells (R-TECs)
R-TECs were isolated from kidneys obtained from
Sprague-Dawley rats and cultured in K1 medium
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Fig. 3. The effect of quercetin pretreatment on the induction
of heat shock protein (Hsp70). Quercetin pretreatment [Q
+geranylgeranylacetone (GGA)] significantly suppressed the
expression of Hsp70 in rat kidneys induced by GGA administration.
∗P < 0.05; ∗∗P < 0.01 versus rats treated with vehicle.
[224.25 mL Ham’s/F-12, 226.25 mL Dulbecco’s modified
Eagle’s medium (DMEM), and 12.5 mL Hepes) con-
taining 10% fetal bovine serum (FBS) and hormones as
described previously [21] with minor modification. The
R-TECs displayed strong alkaline phosphatase reactivity
and were identified by antibodies for cytokeratin (Labsys-
tems, Helsinki, Finland) and GP330 [22], which are mark-
ers of proximal tubules. After reaching confluence (1 ×
107/10 cm dish), R-TECs were washed with phosphate-
buffered saline (PBS).
In vitro experimental design
First, the induction of Hsp70 by GGA was studied in
R-TECs. GGA and vehicle were prepared as described
previously [23]. Confluent primary cultures of R-TECs
were incubated for 2 hours at 37◦C with serial con-
centrations of GGA (0, 0.1, 1, 10, and 100 lmol/L) or
vehicle in Hank’s balanced salt solution without phe-
nol red (HBSS) supplemented with 0.1% FBS, and the
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Fig. 4. Histopathology. Sections from the vehicle-treated rats (A and
D) showed tubular cast formation, tubular dilatation and tubular degen-
eration (vacuolar change, loss of brush border, detachment of tubular
epithelial cells, and condensation of tubular nuclei) occurred mainly
in the outer medulla of the kidney. Kidney sections from rats treated
with geranylgeranylacetone (GGA) (B and E) showed only mild tubu-
lar damage. Pretreatment with quercetin cancelled the effects of GGA
(C and F). (A through C) low-power (40×); (D through F) high-power
(400×) views of the kidney section stained with periodic acid-Schiff
(PAS).
expression of Hsp70 was studied by Western blot. The
time course of Hsp70 expression was also studied after
administration of 10 lmol/L GGA or vehicle.
Next, the cytoprotective effects of GGA were stud-
ied. Preconditioning R-TECs with GGA (10 lmol/L) or
vehicle was performed for 2 hours, followed by a fur-
ther 2-hour incubation with oxidative stress condition
(0.5 mmol/L hydrogen peroxide) or ischemic condition
(2 nmol/L NaCN and 20 mmol/L 2-deoxyglucose in the
absence of medium glucose) [24]. Upon completion of in-
cubation, apoptotic cell death was analyzed by terminal
deoxynucleotidyl transferase (TdT)-mediated deoxyuri-
dine triphosphate (dUTP) nick-end labeling (TUNEL)
assay.
Western blot analysis
Western blot analysis was performed as described pre-
viously [21] with minor modification. Briefly, the whole
kidney preparations or cultured cells were homogenized
in RIPA buffer. Fifty micrograms of proteins were sepa-
rated by 10% sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE), and were electroblotted
onto polyvinylidine difluoride (PVDF) membrane
(Immobilon-Psq) (Millipore, Bedford, MA, USA).
After transferral and blocking with 5% nonfat milk, the
membranes were incubated with antibodies. Primary
antibodies employed were antibodies against Hsp90
(SPA-830), Hsp70 (SPA-810), Hsc70 (SPA-816),
Hsp60 (SPA-806), and Hsp32 (OSA-111) (Stress Gen
Biotechnologies Corp.), and antibodies against b-actin
(Sigma-Aldrich, St. Louis, MO, USA). The secondary
antibodies were goat F(ab′)2 antimouse Ig, horseradish
peroxidase (HRP) conjugate and goat F(ab′)2 antirabbit
Ig, HRP conjugate (Biosource International, Camar-
illo, CA, USA). The proteins were detected using an
enhanced chemiluminescence (ECL) kit (Amersham,
Little Chalfont, UK), quantified using National Institutes
of Health image software, and the expression levels were
presented as ratios to the levels of b-actin expression.
TUNEL assay
Apoptotic cell death was determined on paraffin-
embedded kidney sections (4 lm thick) and R-TECs fixed
in 4% paraformaldehyde by using TUNEL staining with
in situ Apoptosis Detection Kit (Takara, Shiga, Japan).
The number of apoptotic cells in the outer medulla of the
kidney was counted in 16 nonoverlapping fields (×400),
and expressed per 1000 total tubular cells.
Statistical analyses
All values are provided as mean ± SEM. Serial changes
in Hsp70 expression were analyzed by two-way analysis of
variance (ANOVA) followed by Tukey test. The relative
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Fig. 5. Tubular damage and macrophage infiltration. To assess the tubular injury and cast formation, kidney sections were analyzed using a
semiquantitative grading. (A and B) Geranylgeranylacetone (GGA) treatment produced significantly better scores than vehicle treatment. (C)
The number of ED-1–positive cells (macrophages) was also suppressed significantly by GGA administration. Quercetin pretreatment (Q + GGA)
eliminated the effects of GGA. ∗P < 0.05; ∗∗P < 0.01.
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Fig. 6. Apoptotic cells in the kidney. (A) In the vehicle-treated rats,
terminal deoxynucleotidyl transferase (TdT)-mediated deoxyuridine
triphosphate (dUTP) nick-end labeling (TUNEL)-positive cells were
localized mainly in the outer medulla. (B) In the geranylgeranylace-
tone (GGA)-treated rats, fewer apoptotic cells were observed. (D) The
numbers of TUNEL-positive cells are expressed per 100 total tubular
cells. GGA significantly suppressed apoptotic cell death of the tubules.
(C and D) Quercetin pretreatment (Q + GGA) eliminated the effects
of GGA. ∗∗P < 0.01.
density of HSPs, the level of BUN and serum creatinine,
and the number of TUNEL and ED-1–positive cells were
analyzed with Student t test. The score of tubular injury
and cast formation were compared by Mann-Whitney’s
U test. A significant difference was defined as a P value
of less than 0.05.
RESULTS
In vivo experiments
Renal expression of the HSPs. The effects of various
dosages of GGA on the expression of Hsp70 were as-
sessed at 24 hours after oral GGA administration. Hsp70
expression increased significantly in rats given 400 mg/kg
GGA, but a dose of 800 mg/kg did not induce further in-
crease in Hsp70 expression (Fig. 1A). Because the result
showed that the optimal dosage to induce Hsp70 in rat
kidneys was 400 mg/kg, the following experiments were
performed with this dosage. Immunohistochemistry re-
vealed that a low level expression of Hsp70 was observed
in the normal rat kidney. GGA administration enhanced
the expression of Hsp70 especially in the inner stripe
of outer medulla (Fig. 1B and C). Sections incubated
with normal mouse IgG as a primary antibody showed
negative staining (data not shown). The expression of
other HSPs (Hsp90, Hsc70, Hsp60, and Hsp32) was also
analyzed at 24 hours after administration of vehicle or
GGA. No significant difference in the expression of these
HSPs was observed between the control and GGA groups
(Fig. 1D).
The time course of Hsp70 expression was studied af-
ter a single oral dose of GGA (400 mg/kg). Hsp70 had
started to increase by 12 hours after GGA administra-
tion, peaked at 24 hours, and declined by 48 hours. No
time-dependent change was observed in the expression
of Hsp70 in the vehicle group (Fig. 2). Hsp70 expres-
sion was also examined at 48 hours, after two oral doses
(at 0 hour and 24 hours) of GGA (400 mg/kg). The peak
level of Hsp70 expression was comparable to that induced
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Fig. 7. Effects of geranylgeranylacetone (GGA) on renal function.
Rats which underwent renal ischemic/reperfusion (I/R) (vehicle) ex-
hibited significant increases in the levels of blood urea nitrogen (BUN)
and serum creatinine at 24 hours after I/R injury. Preconditioning
with GGA significantly suppressed these increases. Again, pretreat-
ment with quercetin (Q + GGA) cancelled the renoprotective effect
of GGA (A and B). Time course of renal function after I/R injury
was also studied (C and D). Rats were treated with GGA (400 mg/kg)
(N = 6) or a vehicle (N = 6) at 24 hours and 1 hour before the surgery,
and blood samples were taken sequentially. Preconditioning with GGA
significantly suppressed the increases in the levels of of BUN and serum
creatinine. ∗P < 0.05; ∗∗P < 0.01.
by a single oral dose at 24 hours, suggesting that high lev-
els of Hsp70 were maintained even at 48 hours by giving
two oral doses (Fig. 2). The effect of quercetin, which
is shown to be an inhibitor of Hsp70 [25], was studied.
Quercetin pretreatment significantly suppressed the ex-
pression of Hsp70 in rat kidneys induced by GGA ad-
ministration (Fig. 3).
Effects of GGA on renal histology. Examination of
PAS-stained kidney sections from the vehicle-treated
rats showed that tubular injury occurred mainly in the
outer medulla of the kidney. GGA attenuated the injury
(Fig. 4). The severity of the tubular damage, including
tubular dilatation and degeneration (vacuolar change,
loss of brush border, detachment of tubular epithelial
cells, and condensation of tubular nuclei), and cast forma-
tion was scored. Preconditioning with GGA resulted in
significantly better scores in both tubular damage (1.7 ±
0.2 vs. 0.8 ± 0.3) (P < 0.01) and cast formation (1.4 ±
0.2 vs. 0.5 ± 0.1) (P < 0.01) (Fig. 5A and B). The num-
ber of macrophages detected by ED-1 staining was also
suppressed significantly by GGA administration (P <
0.01) (Fig. 5C). These renoprotective effects of GGA
were eliminated by pretreatment with quercetin (Figs. 4
and 5).
In order to study the contribution of apoptosis to this
process, TUNEL assay was performed. In the vehicle-
treated rats, TUNEL-positive cells were localized mainly
in the outer medulla. GGA significantly decreased the
number of TUNEL-positive cells in the outer medulla
of the kidney (3.7 ± 0.6% vs. 1.6 ± 0.3%) (P < 0.01).
Quercetin pretreatment cancelled the antiapoptotic ef-
fect of GGA (Fig. 6).
Effects of GGA on renal function.
Rats which underwent renal I/R exhibited significant
increases in the levels of BUN and serum creatinine. Pre-
conditioning with GGA significantly suppressed these in-
creases. Again, treatment with quercetin suppressed the
effect of GGA (Fig. 7).
In vitro experiments
Induction of Hsp70 in R-TECs. Next, we studied the
effects of GGA using cultured renal epithelial cells, R-
TECs. Western blot analysis showed that 10 lmol/L GGA
significantly enhanced Hsp70 expression. The result was
not different from that observed after incubation with 100
lmol/L GGA (Fig. 8A and C). The time course analysis
of Hsp70 expression demonstrated that 10 lmol/L GGA
induced a transient increase in the protein level of Hsp70
in R-TECs, which peaked at 1 to 2 hours, followed by a
rapid decline by 8 hours (Fig. 8B and D). The expression
of other HSPs (Hsp90, Hsc70, Hsp60, and Hsp32) was
not affected by GGA administration (Fig. 8E).
Apoptosis in R-TECs by hydrogen peroxide. In order
to study the tubular damage by oxidative stress, R-TECs
were incubated in culture medium containing 0.5 mmol/L
hydrogen peroxide. A significant number of TUNEL-
positive cells were observed in R-TECs treated with
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Fig. 8. Induction of heat shock protein
(Hsp70) in rat primary cultures of tubu-
lar epithelial cells (R-TECs). Western blot
analysis showed that 10 lmol/L geranylger-
anylacetone (GGA) significantly enhanced
Hsp70 expression. The result was not different
from that observed after incubation with 100
lmol/L GGA (see Fig. 7A and C). The time
course analysis of Hsp70 expression demon-
strated that 10 lmol/L GGA induced a tran-
sient increase in the protein level of Hsp70
in R-TECs, which peaked at 2 to 4 hours,
followed by a rapid decline by 8 hours (see
Fig. 7B and D). The expression of other HSPs
(Hsp90, Hsc70, Hsp60, and Hsp32) was not af-
fected by GGA administration (see Fig. 7E).
∗∗P < 0.01.
vehicle. GGA preconditioning significantly attenuated
the number of TUNEL-positive cells (6.3 ± 1.0% vs. 0.7
± 0.3) (P < 0.01) (Fig. 9A to C).
We then studied the effects of GGA on tubular damage
by adenosine triphosphate (ATP) depletion. A significant
number of TUNEL-positive cells were observed when
R-TECs were treated in pharmacologic ischemia. GGA
preconditioning significantly attenuated the number of
TUNEL-positive cells (12.1 ± 1.8% vs. 4.2 ± 2.0%) (P <
0.05) (Fig. 9D to F).
DISCUSSION
The present study examined the effect of GGA on the
kidney. Oral administration of GGA induced the expres-
sion of Hsp70, but not Hsp32, Hsp60, or Hsp90. Precondi-
tioning with GGA markedly ameliorated I/R renal injury
by both functional and histologic criteria.
In response to a wide variety of stresses, such as heat
shock, hypoxia, hydrogen peroxide, inflammation, and
ischemia, there is an increase in the expression of HSPs,
which are known to have a cytoprotective function as
molecular chaperons [26]. Indeed, overproduction of
HSPs in the kidney induced by whole-body hyperther-
mia or ischemic preconditioning was shown to increase
resistance to subsequent I/R injury [27–29]. Precondition-
ing the kidney with toxic reagents, such as cyclosporine
or FK506 [30], also induces ischemic tolerance in the kid-
ney. Several other reagents which enhance the expression
of HSPs in the kidney have also been studied. Sodium
arsenite reportedly inhibits apoptotic cell death in rat
kidney with I/R or cyclosporine-induced injuries [31], and
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Fig. 9. Apoptosis in rat primary cultures of tubular epithelial cells
(R-TECs). R-TECs were incubated in culture medium containing 0.5
mmol/L hydrogen peroxide. A significant number of terminal de-
oxynucleotidyl transferase (TdT)-mediated deoxyuridine triphosphate
(dUTP) nick-end labeling (TUNEL)-positive cells were observed in R-
TECs treated with vehicle (A). Geranylgeranylacetone (GGA) precon-
ditioning significantly attenuated the number of TUNEL-positive cells
(B). The difference was statistically significant (C). A significant num-
ber of TUNEL-positive cells were also observed when R-TECs were
treated in pharmacologic ischemia (D). GGA preconditioning signifi-
cantly attenuated the number of TUNEL-positive cells (E and F). ∗P
< 0.05; ∗∗P < 0.01.
administration of cobalt protoporphyrin attenuates I/R-
induced apoptosis and improves survival in rat renal allo-
grafts [32]. In those studies, the Hsp70 family is suggested
to play the major role in renoprotection.
Hsp70 is one of the most fundamental and prominent
stress proteins induced in almost all cell types, and it plays
a role in cell survival [33–35]. In stress conditions, dena-
tured or aggregated proteins accumulate within the cell.
Hsp70 stabilizes these proteins and facilitates their re-
moval or repair, leading to cytoprotection. [36]. In ad-
dition, Hsp70 exerts antiapoptotic effects by interfer-
ing with the stress-induced apoptotic cascade [37, 38].
In fact, the role of Hsp70 in attenuating I/R injury has
been directly documented in transfected cells or trans-
genic murine tissues overexpressing Hsp70 protein [24,
39, 40]. It was also reported that induction of Hsp70 to
the kidney by means of hemagglutinating virus of Japan
(HVJ)-liposome gene transfer method improved func-
tion of the rat renal graft [41]. The relationship between
Hsp72 expression and ischemic tolerance has recently
been suggested in rats [42]. Moreover, an association be-
tween Hsp72 gene polymorphism and ARF in premature
neonates was recently demonstrated by Fekete et al [43].
They reported that that in very low birth weight neonates
carrying Hsp72 (1267) GG genetic variation, which is as-
sociated with low inducibility of Hsp72, the risk of ARF
was higher. These results further suggest that the Hsp70
family protects the kidney from acute damage and that
the induction of Hsp70 would be a good strategy to pro-
tect the kidney from subsequent insult.
GGA, an antiulcer drug, is known to induce Hsp70
in the organs. Intragastric administration of GGA in-
duced HSPs in the gastric mucosa and reduced ulcer for-
mation [15]. In the heart, GGA administration induced
Hsp70, but not Hsp27 or Hsp60. The induction peaked at
24 hours, resulting in cardioprotection [17]. In contrast,
preconditioning with GGA did not increase the protein
level of HSPs in the liver. Instead, preconditioning with
GGA increased the capacity for induction of Hsp70 and
Hsp90 after liver damage, such as heat stress, ischemia or
95% hepatectomy, leading to hepatoprotection [18, 19,
44]. However, to date, the effects of GGA on the kidney
have not been clarified. Our study demonstrated that a
single oral GGA readily induced the expression of Hsp70
in the kidney, which peaked at 24 hours. A similar level of
Hsp70 was observed at 24 hours after a second oral dose.
Other HSPs, including Hsp90, Hsc70, Hsp60 and Hsp32,
showed no fluctuation after GGA administration. The
mechanisms by which GGA induces Hsp70 in the kid-
ney remain to be elucidated. It is reported that in gastric
mucosa GGA could directly activate heat shock factor
1 (HSF1), induce the expression of Hsp70 mRNA, and
cause the accumulation of Hsp70 protein [15]. Similar
mechanisms may act for the induction of renal Hsp70.
In examining the GGA renoprotection process, we
treated rats with quercetin, an inhibitor to the induc-
tion of HSPs [25]. Quercetin suppressed the expression
of Hsp70, and eliminated the therapeutic effects of GGA
on I/R injury. It is certainly possible that broad classes of
renoprotective molecules other than HSPs are also being
induced and functioning in concert with Hsp70 during
I/R injury. Nonetheless, our results strongly suggest that
Hsp70 is a key molecule for the renoprotective properties
of GGA.
In order to further study the antiapoptotic propertiy of
GGA, we performed in vitro experiments using primary
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cultures of tubular epithelial cells. TUNEL assay demon-
strated that both oxidative stress (by hydrogen peroxide)
and ischemic stimuli (by ATP depletion) induced a sub-
stantial degree of apoptosis as was consistent with the in
vivo results. Furthermore, the numbers of apoptotic cells
were significantly attenuated by GGA. The data suggest
that GGA exerts its renoprotective action by suppress-
ing apoptosis in the renal epithelial cells. Concerning
the signal transductions involved in the cytoprotective
effects of GGA, the role of c-Jun NH2-terminal kinase
(JNK) activation was demonstrated in a previous study.
GGA suppressed the insult-induced activation of JNK in
hepatic cells, decreased activation of caspase-9, and sig-
nificantly inhibited apoptosis [23]. It was also reported
previously that Hsp70 inhibits apoptosis by preventing
stress-induced activation of JNK and p38 [45, 46]. From
these findings, it can be postulated that Hsp70, which is
induced by GGA, down-regulates the activation of stress
kinases (JNK and p38), suppresses activation of caspases,
and thus contributes to attenuation of apoptosis in renal
tubular cells. Nonetheless, other mechanisms are still pos-
sible for antiapoptotic effects of Hsp70 [47]. Activation
of p38 is also known to induce inflammation in the kidney
[48]. The ability of Hsp70 to activate p38 may have con-
tributed to the reduction in the macrophage infiltration
in this study.
To date, numerous reagents have successfully been
shown to have renoprotective properties in animal stud-
ies. Some of them, including anti-TNF-a antibodies, solu-
ble TNF receptor fusion proteins, L-omega-mono-methy-
L-arginine (L-NMMA) and ET antagonist, have already
been applied to humans. However, none of them has been
proven to be effective in the clinical setting. Rather, in
some cases, the agent was found to have major side ef-
fects in humans [3]. In this context, we consider that GGA
may have great potential since it is known to be a non-
toxic inducer of Hsp70. A recent report demonstrated
success in building up a renal tolerance using a pharma-
cologic agent which is not toxic and is widely used for
humans. Recombinant human erythropoietin (rHuEpo),
injected in the clinical setting, induced the expression of
Hsp70, rendering protection against I/R renal injury [25].
Their therapeutic concept was similar to ours. However,
increase in hemoglobin concentration by rHuEpo may
induce adverse effects such as hypertension. Moreover,
drugs which can be administered orally may be more fea-
sible. Although the beneficial effects of GGA in ischemic
ARF or kidney transplants should be further assessed,
our data suggest that GGA shows therapeutic potential
for renoprotection.
CONCLUSION
The results of our study provide the first evidence that
oral administration of GGA induces Hsp70 expression
in the rat kidney and that it is associated with renopro-
tective properties after warm ischemia. Because GGA
has long been used in Japan for the treatment of gastric
ulcers or gastritis without major side effects [49], these
findings may have immediate therapeutic implications for
humans.
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